# Armstrong World Industries Inc: financial statements, quarterly

AWI · NYSE · CIK 7431 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/awi.md) · [Financials](/companies/awi/financials.md) · [Filings](/companies/awi/filings.md) · [Insiders](/companies/awi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/awi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [312 d](/filings/0001193125-26-065183.md) | [326](/filings/0000950170-25-059548.md) | [365](/filings/0000950170-25-099377.md) | [387](/filings/0001193125-25-252201.md) | [368 d](/filings/0001193125-26-065183.md) | [383](/filings/0001193125-26-183484.md) | [425](/filings/0001193125-26-318838.md) | [425](/filings/0001193125-26-432651.md) | [388 d](/filings/0001193125-26-065183.md) | [410](/filings/0001193125-26-183484.md) | [472](/filings/0001193125-26-318838.md) | [476](/filings/0001193125-26-432651.md) |
| Cost of revenue | $m | [193 d](/filings/0001193125-26-065183.md) | [202](/filings/0000950170-25-059548.md) | [216](/filings/0000950170-25-099377.md) | [223](/filings/0001193125-25-252201.md) | [224 d](/filings/0001193125-26-065183.md) | [233](/filings/0001193125-26-183484.md) | [249](/filings/0001193125-26-318838.md) | [247](/filings/0001193125-26-432651.md) | [234 d](/filings/0001193125-26-065183.md) | [255](/filings/0001193125-26-183484.md) | [277](/filings/0001193125-26-318838.md) | [285](/filings/0001193125-26-432651.md) |
| Gross profit | $m | [120 d](/filings/0001193125-26-065183.md) | [124](/filings/0000950170-25-059548.md) | [149](/filings/0000950170-25-099377.md) | [164](/filings/0001193125-25-252201.md) | [144 d](/filings/0001193125-26-065183.md) | [150](/filings/0001193125-26-183484.md) | [176](/filings/0001193125-26-318838.md) | [179](/filings/0001193125-26-432651.md) | [155 d](/filings/0001193125-26-065183.md) | [155](/filings/0001193125-26-183484.md) | [195](/filings/0001193125-26-318838.md) | [191](/filings/0001193125-26-432651.md) |
| Selling, general and administrative | $m | [73.3 d](/filings/0001193125-26-065183.md) | [65.4](/filings/0000950170-25-059548.md) | [80.6](/filings/0000950170-25-099377.md) | [77.6](/filings/0001193125-25-252201.md) | [85.4 d](/filings/0001193125-26-065183.md) | [78.0](/filings/0001193125-26-183484.md) | [84.4](/filings/0001193125-26-318838.md) | [90.1](/filings/0001193125-26-432651.md) | [87.4 d](/filings/0001193125-26-065183.md) | [88.4](/filings/0001193125-26-183484.md) | [93.7](/filings/0001193125-26-318838.md) | [91.3](/filings/0001193125-26-432651.md) |
| Operating income | $m | [66.3 d](/filings/0001193125-26-065183.md) | [86.1](/filings/0000950170-25-059548.md) | [95.0](/filings/0000950170-25-099377.md) | [111](/filings/0001193125-25-252201.md) | [81.9 d](/filings/0001193125-26-065183.md) | [98.5](/filings/0001193125-26-183484.md) | [123](/filings/0001193125-26-318838.md) | [117](/filings/0001193125-26-432651.md) | [92.0 d](/filings/0001193125-26-065183.md) | [94.2](/filings/0001193125-26-183484.md) | [134](/filings/0001193125-26-318838.md) | [131](/filings/0001193125-26-432651.md) |
| Interest expense | $m | [8.6 d](/filings/0001193125-26-065183.md) | [9.0](/filings/0000950170-25-059548.md) | [11.1](/filings/0000950170-25-099377.md) | [10.5](/filings/0001193125-25-252201.md) | [9.2 d](/filings/0001193125-26-065183.md) | [8.5](/filings/0001193125-26-183484.md) | [8.6](/filings/0001193125-26-318838.md) | [8.2](/filings/0001193125-26-432651.md) | [7.7 d](/filings/0001193125-26-065183.md) | [7.3](/filings/0001193125-26-183484.md) | [7.8](/filings/0001193125-26-318838.md) | [7.5](/filings/0001193125-26-432651.md) |
| Income tax | $m | [13.9 d](/filings/0001193125-26-065183.md) | [20.3](/filings/0000950170-25-059548.md) | [21.2](/filings/0000950170-25-099377.md) | [26.9](/filings/0001193125-25-252201.md) | [13.8 d](/filings/0001193125-26-065183.md) | [21.6](/filings/0001193125-26-183484.md) | [27.5](/filings/0001193125-26-318838.md) | [23.2](/filings/0001193125-26-432651.md) | [19.3 d](/filings/0001193125-26-065183.md) | [21.6](/filings/0001193125-26-183484.md) | [30.2](/filings/0001193125-26-318838.md) | [32.5](/filings/0001193125-26-432651.md) |
| Net income | $m | [46.8 d](/filings/0001193125-26-065183.md) | [59.9](/filings/0000950170-25-059548.md) | [65.9](/filings/0000950170-25-099377.md) | [76.9](/filings/0001193125-25-252201.md) | [62.2 d](/filings/0001193125-26-065183.md) | [69.1](/filings/0001193125-26-183484.md) | [87.8](/filings/0001193125-26-318838.md) | [86.3](/filings/0001193125-26-432651.md) | [65.5 d](/filings/0001193125-26-065183.md) | [66.8](/filings/0001193125-26-183484.md) | [96.7](/filings/0001193125-26-318838.md) | [91.9](/filings/0001193125-26-432651.md) |
| Diluted EPS | $ per share | not reported | [1.36](/filings/0000950170-25-059548.md) | [1.50](/filings/0000950170-25-099377.md) | [1.75](/filings/0001193125-25-252201.md) | not reported | [1.58](/filings/0001193125-26-183484.md) | [2.01](/filings/0001193125-26-318838.md) | [1.98](/filings/0001193125-26-432651.md) | not reported | [1.55](/filings/0001193125-26-183484.md) | [2.26](/filings/0001193125-26-318838.md) | [2.17](/filings/0001193125-26-432651.md) |
| Basic EPS | $ per share | not reported | [1.37](/filings/0000950170-25-059548.md) | [1.50](/filings/0000950170-25-099377.md) | [1.76](/filings/0001193125-25-252201.md) | not reported | [1.59](/filings/0001193125-26-183484.md) | [2.02](/filings/0001193125-26-318838.md) | [2.00](/filings/0001193125-26-432651.md) | not reported | [1.56](/filings/0001193125-26-183484.md) | [2.28](/filings/0001193125-26-318838.md) | [2.18](/filings/0001193125-26-432651.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [70.8](/filings/0000950170-25-026060.md) | [69.6](/filings/0000950170-24-050195.md) | [73.6](/filings/0000950170-24-087500.md) | [73.7](/filings/0000950170-24-117930.md) | [79.3](/filings/0001193125-26-065183.md) | [82.8](/filings/0000950170-25-059548.md) | [81.1](/filings/0000950170-25-099377.md) | [90.1](/filings/0001193125-25-252201.md) | [113](/filings/0001193125-26-432651.md) | [79.8](/filings/0001193125-26-183484.md) | [78.6](/filings/0001193125-26-318838.md) | [71.4](/filings/0001193125-26-432651.md) |
| Current assets | $m | [313](/filings/0000950170-25-026060.md) | [331](/filings/0000950170-24-050195.md) | [351](/filings/0000950170-24-087500.md) | [358](/filings/0000950170-24-117930.md) | [349](/filings/0001193125-26-065183.md) | [372](/filings/0000950170-25-059548.md) | [376](/filings/0000950170-25-099377.md) | [396](/filings/0001193125-25-252201.md) | [392](/filings/0001193125-26-432651.md) | [402](/filings/0001193125-26-183484.md) | [425](/filings/0001193125-26-318838.md) | [427](/filings/0001193125-26-432651.md) |
| Total assets | $m | [1,672](/filings/0000950170-25-026060.md) | [1,692](/filings/0000950170-24-050195.md) | [1,820](/filings/0000950170-24-087500.md) | [1,804](/filings/0000950170-24-117930.md) | [1,843](/filings/0001193125-26-065183.md) | [1,854](/filings/0000950170-25-059548.md) | [1,862](/filings/0000950170-25-099377.md) | [1,893](/filings/0001193125-25-252201.md) | [1,925](/filings/0001193125-26-432651.md) | [1,986](/filings/0001193125-26-183484.md) | [2,007](/filings/0001193125-26-318838.md) | [2,004](/filings/0001193125-26-432651.md) |
| Current liabilities | $m | [195](/filings/0000950170-25-026060.md) | [184](/filings/0000950170-24-050195.md) | [200](/filings/0000950170-24-087500.md) | [218](/filings/0000950170-24-117930.md) | [250](/filings/0001193125-26-065183.md) | [232](/filings/0000950170-25-059548.md) | [233](/filings/0000950170-25-099377.md) | [261](/filings/0001193125-25-252201.md) | [267](/filings/0001193125-26-432651.md) | [262](/filings/0001193125-26-183484.md) | [280](/filings/0001193125-26-318838.md) | [294](/filings/0001193125-26-432651.md) |
| Long-term debt | $m | [564](/filings/0000950170-25-026060.md) | [559](/filings/0000950170-24-050195.md) | [622](/filings/0000950170-24-087500.md) | [533](/filings/0000950170-24-117930.md) | [503](/filings/0001193125-26-065183.md) | [497](/filings/0000950170-25-059548.md) | [462](/filings/0000950170-25-099377.md) | [386](/filings/0001193125-25-252201.md) | [396](/filings/0001193125-26-432651.md) | [469](/filings/0001193125-26-183484.md) | [482](/filings/0001193125-26-318838.md) | [459](/filings/0001193125-26-432651.md) |
| Current portion of debt | $m | [22.5](/filings/0000950170-25-026060.md) | [22.5](/filings/0000950170-24-050195.md) | [22.5](/filings/0000950170-24-087500.md) | [22.5](/filings/0000950170-24-117930.md) | [22.5](/filings/0001193125-26-065183.md) | [22.5](/filings/0000950170-25-059548.md) | [22.5](/filings/0000950170-25-099377.md) | [22.5](/filings/0001193125-25-252201.md) | [10.3](/filings/0001193125-26-432651.md) | [10.3](/filings/0001193125-26-183484.md) | [10.3](/filings/0001193125-26-318838.md) | [10.3](/filings/0001193125-26-432651.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [592](/filings/0001193125-26-065183.md) | [627](/filings/0000950170-25-099377.md) | [669](/filings/0001193125-25-252201.md) | [717](/filings/0001193125-25-252201.md) | [757](/filings/0001193125-26-432651.md) | [793](/filings/0001193125-26-318838.md) | [838](/filings/0001193125-26-432651.md) | [889](/filings/0001193125-26-432651.md) | [901](/filings/0001193125-26-432651.md) | [893](/filings/0001193125-26-318838.md) | [884](/filings/0001193125-26-432651.md) | [894](/filings/0001193125-26-432651.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [57.1 d](/filings/0001193125-26-065183.md) | [26.4](/filings/0000950170-25-059548.md) | [57.3 d](/filings/0000950170-25-099377.md) | [96.5 d](/filings/0001193125-25-252201.md) | [86.6 d](/filings/0001193125-26-065183.md) | [41.0](/filings/0001193125-26-183484.md) | [81.6 d](/filings/0001193125-26-318838.md) | [123 d](/filings/0001193125-26-432651.md) | [110 d](/filings/0001193125-26-065183.md) | [32.1](/filings/0001193125-26-183484.md) | [93.8 d](/filings/0001193125-26-318838.md) | [96.2 d](/filings/0001193125-26-432651.md) |
| Capital expenditure | $m | [23.7 d](/filings/0001193125-26-065183.md) | [14.7](/filings/0000950170-25-059548.md) | [19.9 d](/filings/0000950170-25-099377.md) | [19.4 d](/filings/0001193125-25-252201.md) | [28.8 d](/filings/0001193125-26-065183.md) | [19.1](/filings/0001193125-26-183484.md) | [19.9 d](/filings/0001193125-26-318838.md) | [22.6 d](/filings/0001193125-26-432651.md) | [47.8 d](/filings/0001193125-26-065183.md) | [17.7](/filings/0001193125-26-183484.md) | [24.0 d](/filings/0001193125-26-318838.md) | [24.7 d](/filings/0001193125-26-432651.md) |
| Dividends paid | $m | [12.5 d](/filings/0001193125-26-065183.md) | [12.3](/filings/0000950170-25-059548.md) | [12.6 d](/filings/0000950170-25-099377.md) | [12.2 d](/filings/0001193125-25-252201.md) | [13.5 d](/filings/0001193125-26-065183.md) | [13.4](/filings/0001193125-26-183484.md) | [13.8 d](/filings/0001193125-26-318838.md) | [13.4 d](/filings/0001193125-26-432651.md) | [14.6 d](/filings/0001193125-26-065183.md) | [14.7](/filings/0001193125-26-183484.md) | [15.5 d](/filings/0001193125-26-318838.md) | [14.3 d](/filings/0001193125-26-432651.md) |
| Share repurchases | $m | [35.0 d](/filings/0001193125-26-065183.md) | [15.0](/filings/0000950170-25-059548.md) | [10.0 d](/filings/0000950170-25-099377.md) | [15.0 d](/filings/0001193125-25-252201.md) | [16.3 d](/filings/0001193125-26-065183.md) | [22.0](/filings/0001193125-26-183484.md) | [30.4 d](/filings/0001193125-26-318838.md) | [27.0 d](/filings/0001193125-26-432651.md) | [49.5 d](/filings/0001193125-26-065183.md) | [60.6](/filings/0001193125-26-183484.md) | [76.8 d](/filings/0001193125-26-318838.md) | [75.7 d](/filings/0001193125-26-432651.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [45.5](/filings/0000950170-24-050195.md) | [45.0](/filings/0000950170-24-087500.md) | [44.6](/filings/0000950170-24-117930.md) | [44.1](/filings/0000950170-25-059548.md) | [44.0](/filings/0000950170-25-099377.md) | [43.9](/filings/0001193125-25-252201.md) | [43.8](/filings/0001193125-26-183484.md) | [43.7](/filings/0001193125-26-318838.md) | [43.6](/filings/0001193125-26-432651.md) | [43.2](/filings/0001193125-26-183484.md) | [42.7](/filings/0001193125-26-318838.md) | [42.3](/filings/0001193125-26-432651.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 41,833,899 at 2026-10-22, from the cover of the [10-Q filed 2026-10-27](/filings/0001193125-26-432651.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 07:10 ET. No prices; not investment advice.